Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu

ABSTRACTThe world is currently embroiled in a pandemic of coronavirus disease 2019 (COVID-19), a respiratory illness caused by the novel betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The severity of COVID-19 disease ranges from asymptomatic to fatal acute respiratory...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Shock (Augusta, Ga.) Ga.), 2020-10, Vol.54 (4), p.438-450
Hauptverfasser:	Leyfman, Yan, Erick, Timothy K., Reddy, Sandeep S., Galwankar, Sagar, Nanayakkara, Prabath W.B., Di Somma, Salvatore, Sharma, Pushpa, Stawicki, Stanislaw P., Chaudry, Irshad H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus Coinfection - diagnosis Coinfection - therapy Coinfection - virology Coronavirus Infections - complications Coronavirus Infections - diagnosis Coronavirus Infections - drug therapy Coronavirus Infections - therapy COVID-19 Humans Hypoxia - therapy Hypoxia - virology Immunotherapy Influenza, Human - complications Influenza, Human - diagnosis Influenza, Human - therapy Pandemics Pneumonia, Viral - complications Pneumonia, Viral - diagnosis Pneumonia, Viral - therapy SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!